InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 34.62 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $1.771 million which missed the analyst consensus estimate of $2.133 million by 16.97 percent. This is a 0.39 percent decrease over sales of $1.778 million the same period last year.